Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection
Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerab...
Saved in:
Published in | mBio Vol. 10; no. 6 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
03.12.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active
M. tuberculosis
infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.
In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (
n
= 8), latent TB infection (LTBI;
n
= 21), and treated LTBI (LTBItt;
n
= 6) and in uninfected exposed controls (ExC;
n
= 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of
Mycobacterium tuberculosis
infection on chest radiographs. SNORD104 expression decreased during
M. tuberculosis
infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (
P
= 0.03) but not M1-like (
P
= 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.
IMPORTANCE
Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active
M. tuberculosis
infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. |
---|---|
AbstractList | In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (
= 8), latent TB infection (LTBI;
= 21), and treated LTBI (LTBItt;
= 6) and in uninfected exposed controls (ExC;
= 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of
infection on chest radiographs. SNORD104 expression decreased during
infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (
= 0.03) but not M1-like (
= 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.
Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active
infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (P = 0.03) but not M1-like (P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection.In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (P = 0.03) but not M1-like (P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB.IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB ( n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like ( P = 0.03) but not M1-like ( P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB. IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB ( n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like ( P = 0.03) but not M1-like ( P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB. ABSTRACT In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have neglected the other major sncRNA classes in spite of their potential functions in host gene regulation. Using RNA sequencing of whole blood, we have therefore determined expression of miRNA, PIWI-interacting RNA (piRNA), small nucleolar RNA (snoRNA), and small nuclear RNA (snRNA) in patients with TB (n = 8), latent TB infection (LTBI; n = 21), and treated LTBI (LTBItt; n = 6) and in uninfected exposed controls (ExC; n = 14). As expected, sncRNA reprogramming was greater in TB than in LTBI, with the greatest changes seen in miRNA populations. However, substantial dynamics were also evident in piRNA and snoRNA populations. One miRNA and 2 piRNAs were identified as moderately accurate (area under the curve [AUC] = 0.70 to 0.74) biomarkers for LTBI, as were 1 miRNA, 1 piRNA, and 2 snoRNAs (AUC = 0.79 to 0.91) for accomplished LTBI treatment. Logistic regression identified the combination of 4 sncRNA (let-7a-5p, miR-589-5p, miR-196b-5p, and SNORD104) as a highly sensitive (100%) classifier to discriminate TB from all non-TB groups. Notably, it reclassified 8 presumed LTBI cases as TB cases, 5 of which turned out to have features of Mycobacterium tuberculosis infection on chest radiographs. SNORD104 expression decreased during M. tuberculosis infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (P = 0.03) but not M1-like (P = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. Taken together, the results demonstrate that snoRNA and piRNA should be considered in addition to miRNA as biomarkers and pathogenesis factors in the various stages of TB. IMPORTANCE Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect latent and active M. tuberculosis infection. RNA molecules hold great promise in this regard, as their levels of expression may differ considerably between infected and uninfected subjects. We have measured expression changes in the four major classes of small noncoding RNAs in blood samples from patients with different stages of TB infection. We found that, in addition to miRNAs (which are known to be highly regulated in blood cells from TB patients), expression of piRNA and snoRNA is greatly altered in both latent and active TB, yielding promising biomarkers. Even though the functions of many sncRNA other than miRNA are still poorly understood, our results strongly suggest that at least piRNA and snoRNA populations may represent hitherto underappreciated players in the different stages of TB infection. |
Author | Leal-Calvo, Thyago Mello, Fernanda Carvalho de Queiroz Durán, Verónica Pessler, Frank Talbot, Steven Ribeiro-Alves, Marcelo Leung, Janaína Samir, Mohamed Geffers, Robert Saad, Maria Helena Féres de Araujo, Leonardo Silva Tallam, Aravind |
Author_xml | – sequence: 1 givenname: Leonardo Silva surname: de Araujo fullname: de Araujo, Leonardo Silva organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil, Helmholtz Centre for Infection Research, Braunschweig, Germany – sequence: 2 givenname: Marcelo surname: Ribeiro-Alves fullname: Ribeiro-Alves, Marcelo organization: Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil – sequence: 3 givenname: Thyago surname: Leal-Calvo fullname: Leal-Calvo, Thyago organization: Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil – sequence: 4 givenname: Janaína surname: Leung fullname: Leung, Janaína organization: Thoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil – sequence: 5 givenname: Verónica surname: Durán fullname: Durán, Verónica organization: Institute for Experimental Infection Research, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany – sequence: 6 givenname: Mohamed surname: Samir fullname: Samir, Mohamed organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Department of Zoonoses, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt – sequence: 7 givenname: Steven surname: Talbot fullname: Talbot, Steven organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany – sequence: 8 givenname: Aravind surname: Tallam fullname: Tallam, Aravind organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany – sequence: 9 givenname: Fernanda Carvalho de Queiroz surname: Mello fullname: Mello, Fernanda Carvalho de Queiroz organization: Thoracic Diseases Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil – sequence: 10 givenname: Robert surname: Geffers fullname: Geffers, Robert organization: Helmholtz Centre for Infection Research, Braunschweig, Germany – sequence: 11 givenname: Maria Helena Féres surname: Saad fullname: Saad, Maria Helena Féres organization: Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil – sequence: 12 givenname: Frank surname: Pessler fullname: Pessler, Frank organization: Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany, Helmholtz Centre for Infection Research, Braunschweig, Germany, Centre for Individualised Infection Medicine, Hannover, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31796535$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ksFu1DAQhiNUREvpkSvykUtKbMeJfUHaVkBXWkq1wNmyncnWJbEX21mpT8Lr4uyWiiIxF4_Gv78Zz8zL4sh5B0XxGlfnGBP-bryw_rzCFW1LLJ4VJwSzqmwZxkez3-CSYCKOi7MY76pslGJOqxfFMcWtaBhlJ8WvNWyD3wQ1jtZtkO_R11ENA7r2zvhuDq2vF-jGb6dBJetdRNahGwh2ewtBDehi8L5Da9iBGiK68jGhXNOowg8IEfU-oJVK4BJSrkMLk-wO0Od747UyKVOmEaVJQzDT4KONaOl6MHOeV8XzPhPh7OE8Lb5__PDt8qpcffm0vFysSlMzmsrWkEa3BhqhhCDAKmIY6bTOfTDZsgu90R1hhre8Bi1Y22AKCjRtFChOT4vlgdt5dSe3webS76VXVu4DPmykCsmaAWRX15zxmmOAruZKq4ZpxhrVdwCi0ZBZ7w-s7aRH6Ez-dm7RE-jTG2dv5cbvZMNFJXibAW8fAMH_nCAmOdpoYBiUAz9FSWgealMxSrL0zd-5HpP8mWwWlAeBCT7GAP2jBFdyXh45L4_cL4_EIuvpP3pj037kuVQ7_OfVb1STzWA |
CitedBy_id | crossref_primary_10_1128_mSystems_00163_21 crossref_primary_10_1186_s12964_024_01724_5 crossref_primary_10_1016_j_ijtb_2023_03_023 crossref_primary_10_1016_j_fmre_2023_03_003 crossref_primary_10_1016_j_micres_2020_126674 crossref_primary_10_3389_fcimb_2022_1009901 crossref_primary_10_3389_fimmu_2022_1027472 crossref_primary_10_3390_microorganisms11030626 crossref_primary_10_22207_JPAM_18_1_40 crossref_primary_10_3389_fcimb_2022_850279 crossref_primary_10_3389_fmicb_2021_808250 crossref_primary_10_1016_j_jiph_2021_06_002 crossref_primary_10_1016_j_ebiom_2022_104110 crossref_primary_10_3390_sym13071307 crossref_primary_10_1111_jcmm_15903 crossref_primary_10_1016_j_ijbiomac_2024_132714 crossref_primary_10_3390_cells9102160 crossref_primary_10_3390_ijms21196979 crossref_primary_10_5493_wjem_v15_i1_97460 crossref_primary_10_1186_s12931_024_02988_8 crossref_primary_10_1186_s12931_023_02367_9 crossref_primary_10_3389_fphar_2023_1152915 crossref_primary_10_2147_IDR_S504632 crossref_primary_10_1016_j_diagmicrobio_2024_116172 crossref_primary_10_3390_ijms23084430 crossref_primary_10_1186_s40779_024_00553_4 crossref_primary_10_1002_wsbm_1643 crossref_primary_10_15406_jmen_2022_10_00368 crossref_primary_10_1021_acschembio_3c00251 crossref_primary_10_3390_tropicalmed8020089 |
Cites_doi | 10.1371/journal.pone.0081076 10.1042/bse0540079 10.1016/s0092-8674(02)00718-3 10.1084/jem.178.6.2249 10.1111/j.1574-6976.2012.00331.x 10.1111/jcmm.14093 10.1002/jemt.1090 10.1056/NEJMoa0907847 10.1093/nar/gkq1355 10.1038/nrg3074 10.1186/1471-2180-14-37 10.1016/j.tube.2018.10.009 10.1111/jcmm.12205 10.7326/0003-4819-149-3-200808050-00241 10.1093/bioinformatics/btw660 10.1093/bioinformatics/bts635 10.1186/s12859-018-2047-z 10.1164/ajrccm.161.4.16141 10.1155/2011/814943 10.3389/fmicb.2018.00602 10.1128/CMR.00021-18 10.1186/1471-2164-7-142 10.1371/journal.pone.0075145 10.1016/j.tube.2013.08.004 10.1038/nrm3359 10.1016/S0378-3758(02)00388-9 10.3389/fvets.2016.00022 10.1038/nrdp.2016.76 10.1371/journal.pone.0088909 10.18388/abp.2016_1330 10.1371/journal.pone.0129744 10.3390/biom8040106 10.1093/bioinformatics/btm254 10.1111/imj.12638 10.1093/bioinformatics/btt656 10.14806/ej.17.1.200 10.1093/nar/gkv468 10.1159/000496749 10.1080/2159256X.2015.1086502 10.1373/clinchem.2015.239459 10.1093/infdis/jiu612 10.1186/1471-2164-12-64 10.1183/09031936.00221214 10.1016/j.tim.2018.10.011 10.1006/meth.2001.1262 10.3389/fmicb.2016.01586 10.1093/bioinformatics/btg405 10.1371/journal.pone.0080149 10.1093/nar/gkv954 10.1186/s13059-014-0550-8 10.1371/journal.pmed.1002814 10.1172/jci.insight.87238 10.1183/09031936.00221514 10.3390/genes8120366 10.1155/2015/206849 10.1126/science.1203919 10.1038/nm.4161 10.1093/nar/gkw345 10.1093/nar/gky310 10.1128/mBio.01187-15 10.1038/nri.2016.40 10.32614/RJ-2016-042 10.1002/0471722146 10.1016/j.surg.2015.04.025 10.1093/nar/gkg849 10.1038/nri.2017.69 10.1038/nbt.3682 10.7150/ijbs.13805 10.1128/CVI.00726-13 10.1186/s12864-018-4785-8 10.1093/biostatistics/4.2.249 |
ContentType | Journal Article |
Copyright | Copyright © 2019 de Araujo et al. Copyright © 2019 de Araujo et al. 2019 de Araujo et al. |
Copyright_xml | – notice: Copyright © 2019 de Araujo et al. – notice: Copyright © 2019 de Araujo et al. 2019 de Araujo et al. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1128/mBio.01037-19 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Profiling of the Host sncRNAome in Tuberculosis |
EISSN | 2150-7511 |
ExternalDocumentID | oai_doaj_org_article_d44858481eed48aba65b556afdee96be PMC6890987 31796535 10_1128_mBio_01037_19 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: ; – fundername: ; grantid: iMed – fundername: ; grantid: Science without borders program |
GroupedDBID | --- 0R~ 53G 5VS AAFWJ AAGFI AAUOK AAYXX ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW CITATION DIK E3Z EBS EJD FRP GROUPED_DOAJ GX1 H13 HYE HZ~ KQ8 M48 O5R O5S O9- OK1 P2P PGMZT RHI RNS RPM RSF CGR CUY CVF ECM EIF M~E NPM RHF 7X8 5PM |
ID | FETCH-LOGICAL-c453t-7c26b7ce69a992e502c52dbb150cccc2dbefcbd25c8784eb957613eaeb36aea83 |
IEDL.DBID | M48 |
ISSN | 2161-2129 2150-7511 |
IngestDate | Wed Aug 27 01:14:57 EDT 2025 Thu Aug 21 17:56:27 EDT 2025 Fri Jul 11 12:38:32 EDT 2025 Wed Feb 19 02:30:07 EST 2025 Tue Jul 01 01:52:42 EDT 2025 Thu Apr 24 23:08:12 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | subclinical tuberculosis RNA biosignature sncRNA biomarkers transcriptome piRNA tuberculosis miRNA snRNA snoRNA incipient tuberculosis |
Language | English |
License | Copyright © 2019 de Araujo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c453t-7c26b7ce69a992e502c52dbb150cccc2dbefcbd25c8784eb957613eaeb36aea83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/d44858481eed48aba65b556afdee96be |
PMID | 31796535 |
PQID | 2321660532 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d44858481eed48aba65b556afdee96be pubmedcentral_primary_oai_pubmedcentral_nih_gov_6890987 proquest_miscellaneous_2321660532 pubmed_primary_31796535 crossref_primary_10_1128_mBio_01037_19 crossref_citationtrail_10_1128_mBio_01037_19 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20191203 |
PublicationDateYYYYMMDD | 2019-12-03 |
PublicationDate_xml | – month: 12 year: 2019 text: 20191203 day: 3 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | mBio |
PublicationTitleAlternate | mBio |
PublicationYear | 2019 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_62_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_68_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_66_2 e_1_3_2_60_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_75_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_73_2 e_1_3_2_5_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_79_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_50_2 e_1_3_2_71_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_65_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_63_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_69_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_67_2 e_1_3_2_61_2 e_1_3_2_80_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_53_2 e_1_3_2_76_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_74_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 Haunsberger SJ (e_1_3_2_72_2) 2017; 33 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_78_2 e_1_3_2_2_2 Maechler M (e_1_3_2_77_2) 2019 Liu A (e_1_3_2_12_2) 2009; 2 e_1_3_2_70_2 |
References_xml | – ident: e_1_3_2_57_2 doi: 10.1371/journal.pone.0081076 – ident: e_1_3_2_21_2 doi: 10.1042/bse0540079 – ident: e_1_3_2_20_2 doi: 10.1016/s0092-8674(02)00718-3 – ident: e_1_3_2_47_2 doi: 10.1084/jem.178.6.2249 – ident: e_1_3_2_5_2 doi: 10.1111/j.1574-6976.2012.00331.x – ident: e_1_3_2_54_2 doi: 10.1111/jcmm.14093 – ident: e_1_3_2_28_2 doi: 10.1002/jemt.1090 – ident: e_1_3_2_9_2 doi: 10.1056/NEJMoa0907847 – ident: e_1_3_2_24_2 doi: 10.1093/nar/gkq1355 – ident: e_1_3_2_49_2 – ident: e_1_3_2_17_2 doi: 10.1038/nrg3074 – ident: e_1_3_2_52_2 doi: 10.1186/1471-2180-14-37 – ident: e_1_3_2_43_2 doi: 10.1016/j.tube.2018.10.009 – ident: e_1_3_2_53_2 doi: 10.1111/jcmm.12205 – ident: e_1_3_2_7_2 doi: 10.7326/0003-4819-149-3-200808050-00241 – volume: 33 start-page: 592 year: 2017 ident: e_1_3_2_72_2 article-title: miRNAmeConverter: an R/bioconductor package for translating mature miRNA names to different miRBase versions publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw660 – ident: e_1_3_2_62_2 doi: 10.1093/bioinformatics/bts635 – ident: e_1_3_2_65_2 doi: 10.1186/s12859-018-2047-z – ident: e_1_3_2_30_2 doi: 10.1164/ajrccm.161.4.16141 – ident: e_1_3_2_2_2 doi: 10.1155/2011/814943 – ident: e_1_3_2_15_2 doi: 10.3389/fmicb.2018.00602 – ident: e_1_3_2_46_2 doi: 10.1128/CMR.00021-18 – ident: e_1_3_2_76_2 doi: 10.1186/1471-2164-7-142 – ident: e_1_3_2_39_2 – ident: e_1_3_2_51_2 doi: 10.1371/journal.pone.0075145 – ident: e_1_3_2_14_2 doi: 10.1016/j.tube.2013.08.004 – ident: e_1_3_2_35_2 doi: 10.1038/nrm3359 – ident: e_1_3_2_78_2 doi: 10.1016/S0378-3758(02)00388-9 – ident: e_1_3_2_10_2 doi: 10.3389/fvets.2016.00022 – ident: e_1_3_2_4_2 doi: 10.1038/nrdp.2016.76 – ident: e_1_3_2_55_2 doi: 10.1371/journal.pone.0088909 – ident: e_1_3_2_38_2 doi: 10.18388/abp.2016_1330 – ident: e_1_3_2_40_2 doi: 10.1371/journal.pone.0129744 – volume: 2 start-page: 519 year: 2009 ident: e_1_3_2_12_2 article-title: MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues publication-title: Int J Clin Exp Pathol – ident: e_1_3_2_60_2 – ident: e_1_3_2_34_2 doi: 10.3390/biom8040106 – ident: e_1_3_2_67_2 doi: 10.1093/bioinformatics/btm254 – ident: e_1_3_2_37_2 doi: 10.1111/imj.12638 – ident: e_1_3_2_63_2 doi: 10.1093/bioinformatics/btt656 – ident: e_1_3_2_61_2 doi: 10.14806/ej.17.1.200 – ident: e_1_3_2_75_2 doi: 10.1093/nar/gkv468 – ident: e_1_3_2_50_2 doi: 10.1159/000496749 – ident: e_1_3_2_45_2 doi: 10.1080/2159256X.2015.1086502 – ident: e_1_3_2_25_2 doi: 10.1373/clinchem.2015.239459 – year: 2019 ident: e_1_3_2_77_2 article-title: cluster: cluster analysis basics and extensions publication-title: R package version 2.1.0 – ident: e_1_3_2_36_2 doi: 10.1093/infdis/jiu612 – ident: e_1_3_2_68_2 – ident: e_1_3_2_71_2 doi: 10.1186/1471-2164-12-64 – ident: e_1_3_2_23_2 doi: 10.1183/09031936.00221214 – ident: e_1_3_2_13_2 doi: 10.1016/j.tim.2018.10.011 – ident: e_1_3_2_73_2 doi: 10.1006/meth.2001.1262 – ident: e_1_3_2_31_2 doi: 10.3389/fmicb.2016.01586 – ident: e_1_3_2_70_2 doi: 10.1093/bioinformatics/btg405 – ident: e_1_3_2_3_2 – ident: e_1_3_2_58_2 doi: 10.1371/journal.pone.0080149 – ident: e_1_3_2_80_2 – ident: e_1_3_2_19_2 doi: 10.1093/nar/gkv954 – ident: e_1_3_2_64_2 doi: 10.1186/s13059-014-0550-8 – ident: e_1_3_2_8_2 doi: 10.1371/journal.pmed.1002814 – ident: e_1_3_2_32_2 doi: 10.1172/jci.insight.87238 – ident: e_1_3_2_16_2 doi: 10.1183/09031936.00221514 – ident: e_1_3_2_18_2 doi: 10.3390/genes8120366 – ident: e_1_3_2_22_2 doi: 10.1155/2015/206849 – ident: e_1_3_2_42_2 doi: 10.1126/science.1203919 – ident: e_1_3_2_48_2 doi: 10.1038/nm.4161 – ident: e_1_3_2_66_2 doi: 10.1093/nar/gkw345 – ident: e_1_3_2_74_2 doi: 10.1093/nar/gky310 – ident: e_1_3_2_44_2 doi: 10.1128/mBio.01187-15 – ident: e_1_3_2_11_2 doi: 10.1038/nri.2016.40 – ident: e_1_3_2_79_2 doi: 10.32614/RJ-2016-042 – ident: e_1_3_2_41_2 doi: 10.1002/0471722146 – ident: e_1_3_2_29_2 doi: 10.1016/j.surg.2015.04.025 – ident: e_1_3_2_33_2 doi: 10.1093/nar/gkg849 – ident: e_1_3_2_6_2 doi: 10.1038/nri.2017.69 – ident: e_1_3_2_26_2 doi: 10.1038/nbt.3682 – ident: e_1_3_2_56_2 doi: 10.7150/ijbs.13805 – ident: e_1_3_2_59_2 doi: 10.1128/CVI.00726-13 – ident: e_1_3_2_27_2 doi: 10.1186/s12864-018-4785-8 – ident: e_1_3_2_69_2 doi: 10.1093/biostatistics/4.2.249 |
SSID | ssj0000331830 |
Score | 2.403056 |
Snippet | Tuberculosis is the infectious disease with the worldwide largest disease burden and there remains a great need for better diagnostic biomarkers to detect... In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs) but have... ABSTRACT In tuberculosis (TB), as in other infectious diseases, studies of small noncoding RNAs (sncRNA) in peripheral blood have focused on microRNAs (miRNAs)... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | Adult biomarkers Biomarkers - metabolism biosignature Female Gene Expression Profiling - methods Host-Microbe Biology Humans incipient tuberculosis Latent Tuberculosis - genetics Leukocytes, Mononuclear - metabolism Macrophages - metabolism Male MicroRNAs - genetics Middle Aged miRNA Mycobacterium tuberculosis - pathogenicity piRNA RNA RNA, Small Untranslated - genetics Tuberculosis - genetics |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9QwFA6yIPgi3p11lQjik3Xb5tLkcUZcRnGHZXVh30puxYE2lWkr7C_Zv-tJ2hlmRPHFPpU2tCH5cs53yMl3EHpDdBD9sDaxzKQJBUwkwhQ60SYnslImy-Ip1_MVX17Rz9fseq_UV8gJG-WBx4E7tRA_sKD5DsacCqUVZ5oxrirrnOTaBesLPm8vmIo2mASspltRzVycNot1-z6Np-KCqs6eE4pa_X8imL_nSe45nrMH6P7EGPF87OlDdMf5R-juWEPy5jG6BQo95lg14IVwW-GvjaprvGq9aYNjwperOb7Y1enq8NrjC8Bd1BOo8SJkruNL9xMYY4eXbddj-HYTsnY2HQZKi78AHfU9Vt7iebSO-PzGgBmIMs9Dg_tBu40Z6rZbd_jTlNzln6Crs4_fPiyTqdpCYigjfVKYnOvCOC6VlLljaW5YbrUGxmjggltXGW1zZkQhqNMSIpWMOAXROFdOCfIUHfnWu-cIV0w4UyiaUusoqZiylaB5ISstqCasmKF32-EvzSRFHipi1GUMSXJRhtkq42yVmZyht7vmP0YNjr81XIS53DUK0tnxAQCqnABV_gtQM_R6i4QSllrYP1HetUNXAvnMOA-lNGbo2YiM3a-AhknOCJuh4gAzB305fOPX36OcNxcylaI4_h-df4HuAaOLBS5ScoKO-s3gXgJr6vWruEB-Ac4THNc priority: 102 providerName: Directory of Open Access Journals |
Title | Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31796535 https://www.proquest.com/docview/2321660532 https://pubmed.ncbi.nlm.nih.gov/PMC6890987 https://doaj.org/article/d44858481eed48aba65b556afdee96be |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bi9QwFA6yIvgi3q2XJYL4ZNe2uTR5EJkR11GcYVkdmLeSpKkO9KJtR5xf4t_1JO2MzrKCfSilDb3knJPznfTkOwg9I9qRfuR5mDMThRR0IhQm1aE2CZGFMnHsV7nOF3y2pB9WbPWHUmjswO7S0M7Vk1q25cnP79vXYPCvhgUw4mU1XTcnkV_w5ghAr4JTSp2Nzkek7wdl4pTXzbgkgHFCGLDljnHz4h0OPJQn8r8MfV5MovzLK53eRDdGOIkng_xvoSu2vo2uDQUmt3fQL8DXQwJWBS4KNwX-VKmyxIumNo3zWvh8McFn-yJeHV7X-AyU0pMNlHjq0trxuf0BcLLDs6brMdy7cik9bYcB7-KPgFXrHqs6xxM_dOL51sAY4TmgNxXuN9q2ZlM23brD78fMr_ouWp6-_fxmFo6lGEJDGenD1CRcp8ZyqaRMLIsSw5Jca4CTBjY4tIXRecKMSAW1WkIYExOrIFTnyipB7qGjuqntA4QLJqxJFY1obikpmMoLQZNUFlpQTVgaoBe77s_MyFPuymWUmY9XEpE5aWVeWlksA_R83_zbQNDxr4ZTJ8t9I8er7U807ZdsNNMsh2iVuQoDAB2oUFpxphnjqsitlVzbAD3daUIGduh-rqjaNpsuA2Qac-7qbATo_qAZ-0cBRpOcERag9EBnDt7l8Eq9_uq5vrmQkRTpw__9ykfoOkA6X-EiIo_RUd9u7BOATb0-9tMNsH-3io-9cfwG-1ccZQ |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reprogramming+of+Small+Noncoding+RNA+Populations+in+Peripheral+Blood+Reveals+Host+Biomarkers+for+Latent+and+Active+Mycobacterium+tuberculosis+Infection&rft.jtitle=mBio&rft.au=de+Araujo%2C+Leonardo+Silva&rft.au=Ribeiro-Alves%2C+Marcelo&rft.au=Leal-Calvo%2C+Thyago&rft.au=Leung%2C+Jana%C3%ADna&rft.date=2019-12-03&rft.issn=2161-2129&rft.eissn=2150-7511&rft.volume=10&rft.issue=6&rft_id=info:doi/10.1128%2FmBio.01037-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_mBio_01037_19 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon |